LIFE SCIENCES QUEENSLAND LIMITED (LSQ) @LSQld

LIFE SCIENCES QUEENSLAND LIMITED (LSQ)
Mario Pennisi – CEO
@LSQld
LEADING DESTINATION FOR
CLINICAL RESEARCH
INVESTORS IN QLD INCLUDE:
LIFE SCIENCES IN QLD
• ~300 companies in life sciences
• ~$5B invested by the Queensland
Government
• Queensland is a proven innovation
powerhouse:
• Gardasil, the world’s first cervical
cancer vaccine
• Picato, the first topical therapy to
treat actinic keratosis
• Nanopatch, next generation
needle-free vaccine delivery
• Prof Maree Smith
(Spinifex/Novartis)
• The Excellence in Research for
Australia (ERA) report shows the
QLD research leads the nation
GROWING SCIENTIFIC LINKS
BETWEEN QLD AND ASIA
29 GOVERNMENT FUNDED
BIOTECHNOLOGY RESEARCH INSTITUTES
Institute for Molecular Bioscience (1999)
UQ Centre for Clinical Research (2005)
Institute for Glycomics (2000)
Queensland Brain Institute (2005)
Institute of Health & Biomedical Innovation (2002)
Bionano products Development Facility (2006)
Australian Institute for Bioengineering & Nanotechnology
(2002)
Medical Diagnostics Technologies in QLD (2006)
Institute for Cellular & Molecular Therapies ESKITIS (2003)
Queensland Animal Breeding Facility (2003)
Mackay Renewable Biocommodites Pilot Plant (2006)
Australian Tropical Science and Innovation Precinct (2006)
Mater Medical Research Institute (2003)
Wesley Research Institute Health and Medical Research
Centre (2006)
Wesley Research Institute Clinical Research Centre (2003)
Translational Research Institute (2006)
Centre for Marine Microbiology & Genetics Research (2003)
Ecosciences Precinct (2007)
Centre for Integrated Preclinical Drug Development (2004)
Health and Food Sciences Precinct (2007)
Queensland Crop Development Facility (2004)
Molecular and Clinical Pathology Research Laboratory
(2008)
Centre for Advanced Animal Science (2004)
Medical Engineering Research Facility (2004)
Wesley Research Institute Tissue Bank (2005)
Queensland Compound Library (2005)
Queensland Tropical Health Alliance (2008)
Queensland Institute of Medical Research (2008)
Australian Institute for Tropical Health and Medicine (2012)
SCIENCE INFRASTRUCTURE
Translational Research Institute
Biopharmaceuticals and vaccination
research and translation
Australian Institute for
Bioengineering and
Nanotechnology
•
Protein engineering, drug delivery
and environmental nanotechnology
QIMR Berghofer Medical Research
Institute
Cancer, infectious diseases, mental health
and range of complex diseases
Patheon Biologics
•
a leading global contract
manufacturing service provider for
monoclonal antibodies and
recombinant proteins expressed in
mammalian cell lines.
SCIENCE INFRASTRUCTURE
Institute for Molecular Bioscience
Queensland Brain Institute
•
•
Genetics research and personalised
medicines
Institute of Health and Biomedical
Innovation
Wound research, injury prevention and
chronic disease research
Sensory systems, neural research
and epigenetics
Gold Coast University Hospital
• A 750 bed teaching hospital colocated with Griffith University
opened Q3 2013
SCIENCE INFRASTRUCTURE
Australian Institute of Tropical Health &
Medicine (AITHM)
Centre for Tropical Crops and
Biocommodities
•
•
Biosecurity and tropical infectious diseases,
genomics and cancer research
Working on biofortification of bananas for subSaharan Africa (Bill & Melinda Gates Foundation
Funding)
ESKITIS Institute for Cellular & Molecular
Therapies
Queensland Alliance for Agriculture and
Food Innovation
•
•
•
•
Attracted $100M investment by AstraZeneca
Established Nature Bank of samples plant and
marine invertebrate species and Natural Product
Fractions ~ 600,000 compounds ready to screen
Home to Compounds Australia
Working with DAFF to address problems for
sorghum growers across the world’s low rainfall
regions (Bill & Melinda Gates Foundation Funding)
LEADING DESTINATION FOR
CLINICAL RESEARCH
INVESTORS IN QLD INCLUDE:
WHY?
• Access world calss R&D
• High-quality clinical facilities with state-of-the-art equipment for testing
and analysis
• A fast, pragmatic regulatory pathway and reciprocal arrangements with
regulatory authorities such as the FDA and EMA
• Strong intellectual property protection
• Generous R&D tax incentives (43.5%)
• Ethnically diverse patient cohorts
• Well-characterised tissue banks, for use in precursor studies
• Counter-seasonality with the northern hemisphere
LSQ MEANS BUSINESS
FOR MEMBERS
–
Human Healthcare
(pharmaceuticals / drug delivery,
complementary medicines, functional foods /
beverages, medical devices, diagnostics)
–
Animal Health
–
Agriculture
–
Environmental Biotechnology
–
Industrial Biotechnology
(Bio-energy, Bio-mining)
–
Marine Biotechnology
174 Member
organisations
143 headquartered
in Queensland
Foreign Members
from USA, UK,
Germany,
Singapore, China
and India
REASONS TO WORK WITH LSQ
• Take advantage of Australia’s 43.5% R&D tax
credit
• Access streamlined CTN/CTX schemes for
regulatory approval
• Work with a coordinated, comprehensive peak
industry organisation to facilitate introductions to
leading Australian business entities
• Work closely with State and Federal government
to assist the sector and promote the role of
innovation in economic development
• Host key industry events such as I-20 and
TABBS
• Leveraging $20b Medical Research Future Fund
• Leveraging $185m Advance Queensland plan
HOST OF INNOVATION-20
•
In 2014 LSQ put innovation on the agenda by
hosting the inaugural I-20 summit in Brisbane
during the G20 Leaders’ Summit
•
LSQ is working with the Republic of Turkey who
have incorporated I-20 into the official program of
G20 2015, through T-20
Speakers at I-20 2015 included:
- Josh Lerner, Harvard Business School
- James C Greenwoood, BIO
- Jack Bobo, US Department of State
TABBS – OCTOBER 12, 2015
The Australian Bioenergy and Bioproducts Symposium (TABBS)
Realising the Bioeconomy - It's Hot in the Tropics!
Monday 12th October 2015
Brisbane Convention and Exhibition Centre, Brisbane, Australia
INTERNATIONAL PARTNERS
THANK YOU TO OUR SUPPORTERS